Tag: biomimics 3d

BioMimics 3D stent receives US FDA premarket approval

UK-based Veryan Medical has announced that the company has received premarket approval (PMA) for their BioMimics 3D vascular stent system from the US Food...

MIMICS-3D registry completes enrolment

Veryan Medical has announced completion of enrolment of the 500th patient in the MIMICS-3D pan-European registry, a prospective, multicentre, observational registry to evaluate the...

The value of Swirling Flow and the BioMimics 3D clinical study...

This article is an advertorial by Veryan Medical. Authors: PA Gaines, T Sullivan, G Ansel, C Caro Introduction Medical advances in the treatment of femoropopliteal artery disease...

MIMICS-2 shows 90% freedom from target lesion revascularisation at one year...

The BioMimics 3D (Veryan Medical) helical swirling flow stent system provides an alternative to antiproliferative drugs, according to one-year data from the MIMICS-2 trial....

New Mimics data support use of the BioMimics 3D swirling flow...

New significant outcomes from the Mimics study have been presented at the 15th annual conference on Vascular Interventional Advances (VIVA; 11-14 September, Las Vegas,...

Veryan Medical receives £13.5m further funding

Veryan Medical has received a further £13.5m of funding in the form of both equity and debt from its existing investors, including Touchstone Innovations,...